The Journal of Experimental Medicine
FluoroSpot from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 16 July 2001. doi:10.1084/jem.194.2.143
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 463K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smeltz, R. B.
Right arrow Articles by Shevach, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smeltz, R. B.
Right arrow Articles by Shevach, E. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/7/143/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 2, July 16, 2001 143-154


Original Article

Regulation of Interleukin (IL)-18 Receptor {alpha} Chain Expression on CD4+ T Cells during T Helper (Th)1/Th2 Differentiation: Critical Downregulatory Role of IL-4

Ronald B. Smeltza, June Chena,b, Jane Hu-Lia, and Ethan M. Shevacha
a Laboratory of Immunology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
b Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program, Bethesda, MD 20814

Correspondence to: Ethan M. Shevach, National Institutes of Health, Bldg. 10, Rm. 11N315, Bethesda, MD 20892. Tel:301-496-6449 Fax:301-496-0222 E-mail:ems1{at}mail.nih.gov.

Interleukin (IL)-18 has been well characterized as a costimulatory factor for the induction of IL-12–mediated interferon (IFN)-{gamma} production by T helper (Th)1 cells, but also can induce IL-4 production and thus facilitate the differentiation of Th2 cells. To determine the mechanisms by which IL-18 might regulate these diametrically distinct immune responses, we have analyzed the role of cytokines in the regulation of IL-18 receptor {alpha} chain (IL-18R{alpha}) expression. The majority of peripheral CD4+ T cells constitutively expressed the IL-18R{alpha}. Upon antigen stimulation in the presence of IL-12, marked enhancement of IL-18R{alpha} expression was observed. IL-12–mediated upregulation of IL-18R{alpha} required IFN-{gamma}. Activated CD4+ T cells that expressed low levels of IL-18R{alpha} could produce IFN-{gamma} when stimulated with the combination of IL-12 and IL-18, while CD4+ cells which expressed high levels of IL-18R{alpha} could respond to IL-18 alone. In contrast, T cell stimulation in the presence of IL-4 resulted in a downregulation of IL-18R{alpha} expression. Both IL-4-/- and signal transducer and activator of transcription (Stat)6-/- T cells expressed higher levels of IL-18R{alpha} after TCR stimulation. Furthermore, activated T cells from Stat6-/- mice produced more IFN-{gamma} in response to IL-18 than wild-type controls. Thus, positive/negative regulation of the IL-18R{alpha} by the major inductive cytokines (IL-12 and IL-4) determines the capacity of IL-18 to polarize an immune response.

Key Words: IFN-{gamma}–inducing factor, IL-12, IL-1R–related protein, Stat, IFN-{gamma}


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS